These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intravesical chemotherapy versus immunotherapy for superficial bladder cancer. Huben RP Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):17-22. PubMed ID: 8727806 [TBL] [Abstract][Full Text] [Related]
4. Introduction and overview of intravesical therapy for superficial bladder cancer. Soloway MS Urology; 1988 Mar; 31(3 Suppl):5-16. PubMed ID: 3126593 [TBL] [Abstract][Full Text] [Related]
5. Editorial comment on: Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancer. Evans CP Eur Urol; 2007 Oct; 52(4):1129-30. PubMed ID: 17383082 [No Abstract] [Full Text] [Related]
6. Intravesical instillation of bacille Calmette-Guérin for superficial bladder cancer: cost-effectiveness analysis. Uchida A; Yonou H; Hayashi E; Iha K; Oda M; Miyazato M; Oshiro Y; Hokama S; Sugaya K; Ogawa Y Urology; 2007 Feb; 69(2):275-9. PubMed ID: 17320663 [TBL] [Abstract][Full Text] [Related]
7. Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression. Böhle A; Bock PR Urology; 2004 Apr; 63(4):682-6; discussion 686-7. PubMed ID: 15072879 [TBL] [Abstract][Full Text] [Related]
8. Impact of intravesical chemotherapy versus BCG immunotherapy on recurrence of superficial transitional cell carcinoma of the bladder: metaanalytic reevaluation. Huncharek M; Kupelnick B Am J Clin Oncol; 2003 Aug; 26(4):402-7. PubMed ID: 12902895 [TBL] [Abstract][Full Text] [Related]
9. Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma. Friedrich MG; Pichlmeier U; Schwaibold H; Conrad S; Huland H Eur Urol; 2007 Oct; 52(4):1123-29. PubMed ID: 17383080 [TBL] [Abstract][Full Text] [Related]
10. [Intravesical instillation in the treatment of superficial tumors of the bladder]. Chopin DK Prog Urol; 1998 Apr; 8(2):268-73. PubMed ID: 9615941 [TBL] [Abstract][Full Text] [Related]
11. Complications of intravesical therapy for urothelial cancer of the bladder. Koya MP; Simon MA; Soloway MS J Urol; 2006 Jun; 175(6):2004-10. PubMed ID: 16697786 [TBL] [Abstract][Full Text] [Related]
12. Sustained prophylactic effect of intravesical bacille Calmette-Guérin for superficial bladder cancer: a smoothed hazard analysis in a randomized prospective study. Hinotsu S; Akaza H; Isaka S; Kanetake H; Kubota Y; Kuroda M; Shinohara N; Shinka T; Tachibana M; Naito S; Hirao Y; Urology; 2006 Mar; 67(3):545-9. PubMed ID: 16527576 [TBL] [Abstract][Full Text] [Related]
14. [Postoperative and adjuvant intravesical therapy of superficial bladder tumours. Clinical practice and applied therapeutic agents]. Lingnau A; Miller K; Steiner U; Jentzmik F; Weikert S; Schostak M Aktuelle Urol; 2009 Sep; 40(5):307-9. PubMed ID: 19637135 [TBL] [Abstract][Full Text] [Related]
15. Intravesical antineoplastic therapy following transurethral resection of bladder tumors: nursing implications from the operating room to discharge. Washburn DJ Clin J Oncol Nurs; 2007 Aug; 11(4):553-9. PubMed ID: 17723968 [TBL] [Abstract][Full Text] [Related]
16. [Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony]. Steinbach F; Schuster F Aktuelle Urol; 2005 Aug; 36(4):337-41. PubMed ID: 16110407 [TBL] [Abstract][Full Text] [Related]
17. Results of a randomized phase III trial of sequential intravesical therapy with mitomycin C and bacillus Calmette-Guerin versus mitomycin C alone in patients with superficial bladder cancer. Witjes JA; Caris CT; Mungan NA; Debruyne FM; Witjes WP J Urol; 1998 Nov; 160(5):1668-71; discussion 1671-2. PubMed ID: 9783928 [TBL] [Abstract][Full Text] [Related]
18. Management of bacillus Calmette-Guerin (BCG) refractory superficial bladder cancer: results with intravesical BCG and Interferon combination therapy. Punnen SP; Chin JL; Jewett MA Can J Urol; 2003 Apr; 10(2):1790-5. PubMed ID: 12773228 [TBL] [Abstract][Full Text] [Related]
19. Is intravesical chemotherapy for superficial bladder cancer still justified? Okeke AA; Probert JL; Gillatt DA; Schwaibold H BJU Int; 2005 Oct; 96(6):763-7. PubMed ID: 16153195 [No Abstract] [Full Text] [Related]